The University of Newcastle\u2019s (UoN) Dr Aleona Swegen is in celebration mode as the inaugural winner of the Innovation Accelerator Program.<\/p>\n
As a result, she\u2019ll pocket $200,000 to fast-track the commercialisation of her groundbreaking fertility technology, SpermSafe.<\/p>\n
The announcement follows the conclusion of a 12-week Newcastle Permanent-Hunter Medical Research Institute (HMRI) initiative that supported four exceptional early-career researchers tackling critical health challenges in IVF, stroke, sepsis and hearing loss.<\/p>\n
Dr Swegen, a member of the HMRI\u2019s Infertility and Reproduction Research Program, was selected for her work developing SpermSafe, a storage medium designed to enhance sperm survival and motility while minimising DNA damage during IVF procedures.<\/p>\n
She now looks forward to progressing its clinical application.<\/p>\n
\u201cBeing named the winner of the Newcastle Permanent Innovation Accelerator Program gives me the time, resources and support needed to move SpermSafe beyond the lab and into the real world,\u201d she explained.<\/p>\n
\u201cToo often science never makes it past the research stage.<\/p>\n
\u201cHuman IVF is rightfully a highly-regulated space as we\u2019re trying to help create healthy babies.<\/p>\n
\u201cThis prize will allow me to navigate the regulatory pathway and deliver a product that could help countless families realise their dream of having a baby.\u201d<\/p>\n
The Innovation Accelerator Program, launched earlier this year as part of the $2 million Newcastle Permanent and HMRI partnership, was designed to help early-career scientists and clinicians translate their ideas into healthcare realities.<\/p>\n
All four finalists received $20,000 in seed funding, mentoring and industry connections, culminating in Demo Day presentations to investors, health leaders and industry stakeholders.<\/p>\n
\u201cAleona\u2019s work stood out not just for its scientific rigour, but for its potential to make a truly global impact,\u201d HMRI CEO Professor Frances Kay said.<\/p>\n
\u201cHer innovation aligns perfectly with our mission to turn research into better health.<\/p>\n
\u201cWe\u2019re incredibly proud to support her on this next stage of her journey.<\/p>\n
\u201cThis opportunity has been made possible, thanks to the backing of Newcastle Permanent, and we\u2019re deeply grateful for its investment in future of our people and region.\u201d<\/p>\n
Paul Juergens said the award reflected the organisation\u2019s commitment to backing local innovation that improved community wellbeing.<\/p>\n
\u201cWe know how important our members\u2019 health and wellbeing are to them and their families,\u201d the Newcastle Permanent spokesperson explained.<\/p>\n
\u201cBy supporting Aleona and her breakthrough, we\u2019re helping to turn promising ideas into solutions that can make a lasting difference to people across Australia and beyond. <\/p>\n
\u201cIt\u2019s inspiring to see what\u2019s possible when local talent is empowered to make a difference.\u201d\u00a0<\/p>\n